Neurourology and Urodynamics · 2020 · 17 citations · 22 references
MedicineSurgeryUrologyNeurourologyPain MedicineUrologic SurgeryBladder Function AssessmentOveractive BladderOveractive Bladder ManagementPain OutcomesUrinary Continence AssessmentUrinary IncontinenceDetrusor Overactivity ManagementIdiopathic Detrusor OveractivityIdiopathic Overactive BladderIncontinence Severity MeasurementOveractive Bladder SymptomsPercutaneous Peripheral Nerve StimulationPosterior Tibial Nerve StimulationRefractory Overactive Bladder
AIM: To compare the efficacy of transcutaneous tibial nerve stimulation (TTNS) with percutaneous tibial nerve stimulation (PTNS) regarding patient-reported outcomes measures, specifically quality-of-life (QoL) improvement and patient's treatment benefit, on symptoms associated with overactive bladder (OAB). METHODS: Patients with refractory OAB symptoms and detrusor overactivity were randomized to receive TTNS or PTNS for 12 weeks. Data from self-report OAB questionnaire short form (q-SF) and incontinence (I)-QoL questionnaires were collected pretreatment and at Weeks 6 and 12. Patients' self-perceived benefits on symptoms (treatment benefit scale, TBS) were also gathered. Mean change in scores within and between groups were estimated. RESULTS: Sixty-eight adult patients (67.6% women) were included in the intention to treat analysis. Of those, 61 completed all questionnaires and were analyzed as per protocol. Statistically significant improvements in OAB-q-SF and I-QoL between baseline and end-of-treatment scores were observed in both TTNS and PTNS groups (p < .001), being the differences much higher than the minimal important difference in both questionnaires. The scores of the OAB-q-SF scales (symptoms bother and health-related QoL) showed no statistically significant differences between the two groups. Similarly, the differences regarding the I-QoL questionnaire were statistically nonsignificant either (p = .607). When assessing the treatment benefit on symptoms, TBS responses between groups showed no statistical differences. CONCLUSION: A significant improvement of QoL was observed in both TTNS and PTNS groups. However, no patient-reported outcomes measures scores support a difference between the two groups. Therefore, these findings along with TTNS ease of application and less invasiveness may lead to an increased indication of this technique for OAB.
22
Reporting of Patient-Reported Outcomes in Randomized Trials
Melanie Calvert, Jane Blazeby, Douglas G. Altman et al. · JAMA · 2013 · 1.4K citations
Karin S. Coyne, Christopher Sexton, Debra E. Irwin et al. · British Journal of Urology · 2008 · 827 citations · Full text
Medicine, Internal Medicine, Urology +17